文 献Cell Death Dis 2014; 5(1): e996.8）Wang Z, Lachmann A, Ma'ayan A. Mining data and metadata from the gene expression omnibus. Biophys Rev 2019; 11(1): 103-10.9）Stedman CA, Barclay ML. Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors. Aliment Pharmacol Ther 2000; 14(8): 963-78.10）Suzuki A, Yuen NA, Ilic K, Miller RT, Reese MJ, Brown HR, et al. Comedications alter drug-induced liver injury reporting frequency: Data mining in the WHO VigiBase™. Regul Toxicol Pharmacol 2015; 72(3): 481-90.11）Jia ZL, Cen J, Wang JB, Zhang F, Xia Q, Wang X, et al. Mechanism of isoniazid-induced hepatotoxicity in zebrafish larvae: Activation of ROS-mediated ERS, apoptosis and the Nrf2 pathway. Chemosphere 2019; 227: 541-50.12）Nakatake R, Hishikawa H, Kotsuka M, Ishizaki M, Matsui K, Nishizawa M, et al. The proton pump inhibitor lansoprazole has hepatoprotective effects in in vitro and in vivo rat models of acute liver injury. Dig Dis Sci 2019; 64(10): 2854-66.13）Nishi T, Yamamoto Y, Yamagishi N, Iguchi M, Tamai H, Ito T, et al. Lansoprazole prevents the progression of liver fibrosis in non-alcoholic steatohepatitis model rats. J Pharm Pharmacol 2018; 70(3): 383-92.1241）Fredj NB, Romdhane HB, Woillard JB, Chickaid M, Fadhel NB, Chadly Z, et al. Population Pharmacokinetic model of isoniazid in patients with tuberculosis in Tunisia. Int J Infect Dis 2021; 104: 562-7.2）Baskaran UL, Sabina EP. Clinical and experimental research in antituberculosis drug-induced hepatotoxicity: a review. J Integr Med 2017; 15(1): 27-36.3）Sanjay S, Girish C, Toi PC, Bobby Z. Quercetin modulates NRF2 and NF-κB/TLR-4 pathways to protect against isoniazid-and rifampicin-induced hepatotoxicity in vivo. Can J Physiol Pharmacol 2021; 99(9): 952-63.4）Dabeek WM, Marra MV. Dietary quercetin and kaempferol: bioavailability and potential cardiovascular-related bioactivity in humans. Nutrients 2019; 11(10): 2288.5）Wang K. Molecular mechanisms of hepatic apoptosis. 6）Higuchi A, Wakai E, Tada T, Koiwa J, Adachi Y, Shiromizu T, et al. Generation of a transgenic zebrafish line for in vivo assessment of hepatic apoptosis. Pharmaceuticals (Basel) 2021; 14(11): 1117.7）Wakai E, Suzumura Y, Ikemura K, Mizuno T, Watanabe M, Takeuchi K, et al. An integrated in silico and in vivo approach to identify protective effects of palonosetron in cisplatin-induced nephrotoxicity. Pharmaceuticals (Basel) 2020 ; 13(12): 480.
元のページ ../index.html#138